Acquisition by Azarbarzin Kurt of 5360 shares of Tela Bio at 10.34 subject to Rule 16b-3
| TELA Stock | USD 2.45 0.07 2.78% |
About 61% of Tela Bio's investor base is looking to short. The analysis of overall sentiment of trading Tela Bio stock suggests that many investors are alarmed at this time. The current market sentiment, together with Tela Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Tela Bio stock news signals to limit their universe of possible portfolio assets.
Tela |
Filed transaction by Tela Bio Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Tela Bio Fundamental Analysis
We analyze Tela Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tela Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tela Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Tela Bio is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Tela Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tela Bio stock to make a market-neutral strategy. Peer analysis of Tela Bio could also be used in its relative valuation, which is a method of valuing Tela Bio by comparing valuation metrics with similar companies.
Peers
Tela Bio Related Equities
| TMDX | TransMedics | 5.82 | ||||
| NPCE | Neuropace | 3.11 | ||||
| AXGN | Axogen | 2.99 | ||||
| CLPT | Clearpoint Neuro | 2.18 | ||||
| SIBN | Si Bone | 1.74 | ||||
| DCTH | Delcath Systems | 1.58 | ||||
| KIDS | Orthopediatrics Corp | 1.44 | ||||
| OFIX | Orthofix Medical | 0.99 | ||||
| TCMD | Tactile Systems | 0.56 | ||||
| RXST | Rxsight | 0.53 | ||||
| FNA | Paragon 28 | 0.38 | ||||
| SGHT | Sight Sciences | 0.38 | ||||
| VREX | Varex Imaging | 0.08 | ||||
| CVRX | CVRx | 0.08 | ||||
| TMCI | Treace Medical | 2.08 | ||||
| LUNG | Pulmonx Corp | 6.51 |
Complementary Tools for Tela Stock analysis
When running Tela Bio's price analysis, check to measure Tela Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tela Bio is operating at the current time. Most of Tela Bio's value examination focuses on studying past and present price action to predict the probability of Tela Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tela Bio's price. Additionally, you may evaluate how the addition of Tela Bio to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |